Hospira Joins the Generic Pharmaceutical Association
26 Julho 2004 - 3:37PM
PR Newswire (US)
Hospira Joins the Generic Pharmaceutical Association LAKE FOREST,
Ill., July 26 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE:HSP)
announced today that its membership has been approved by the Board
of Directors of the Generic Pharmaceutical Association (GPhA), an
organization "committed to improving lives for less" by
representing the industry and its nearly 150 member companies
through participation in regulatory, scientific and legislative
forums. "We're pleased to become a part of the leading organization
representing the generic pharmaceutical industry," said Edward A.
Ogunro, Ph.D., senior vice president, Research and Development,
Regulatory and Medical Affairs, and chief scientific officer,
Hospira. "As the leading provider of generic injectable
pharmaceuticals in the United States, we look forward to
contributing an active voice to shaping the future of the industry
-- helping to increase customer awareness and access to generic
pharmaceuticals." Hospira offers the broadest portfolio of generic
injectable pharmaceuticals and drug-delivery systems in the United
States, with products that address critical therapeutic areas
including pain, anesthesia, cardiovascular and infectious disease.
Through these high-quality generic alternatives, Hospira is
strategically positioned to help reduce the overall cost of
healthcare. More than $3 billion of non-biologic branded injectable
drug patents are slated to expire in the United States by the end
of the decade, and Hospira's pipeline should deliver a steady
stream of generic pharmaceuticals to the market. "We are pleased to
welcome Hospira to GPhA, and we look forward to their participation
in the Association's mission to make American healthcare more
affordable," said Kathleen Jaeger, GPhA's president and chief
executive officer. "Hospira's products, like those of our other
members, have enabled millions of Americans to obtain affordable
treatments for critical conditions." About the Generic
Pharmaceutical Association (GPhA) GPhA represents the manufacturers
and distributors of finished generic pharmaceuticals, manufacturers
and distributors of bulk active pharmaceutical chemicals, and
suppliers of other goods and services to the generic drug industry.
Generics represent 51 percent of the total prescriptions dispensed
in the United States, but less than 8 percent of all dollars spent
on prescription drugs. The Generic Pharmaceutical Association is
committed to improving lives for less. For additional information,
visit GPhA's Web site at http://www.gphaonline.org/ . About Hospira
Hospira, Inc. is a global specialty pharmaceutical and medication
delivery company dedicated to Advancing Wellness(TM) by developing,
manufacturing and marketing products that help improve the safety
and efficacy of patient care. Created from the core global hospital
products business of Abbott Laboratories, Hospira is a new company
with 70 years of service to the hospital industry. The company's
portfolio includes one of the industry's broadest lines of generic
acute-care injectables, integrated solutions for medication
management and infusion therapy, and a full-service contract
manufacturing business. Headquartered in Lake Forest, Ill., north
of Chicago, Hospira has more than 14,000 employees and 15
manufacturing facilities worldwide. Hospira's news releases and
other information can be found at http://www.hospira.com/ .
DATASOURCE: Hospira, Inc. CONTACT: Media, Stacey Eisen,
+1-224-212-2276, or Financial Community, Lynn McHugh,
+1-224-212-2363, both of Hospira, Inc. Web site:
http://www.hospira.com/ http://www.gphaonline.org/
Copyright
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jul 2024 até Ago 2024
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Ago 2023 até Ago 2024
Notícias em tempo-real sobre da New York Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Hospira W/I